Stifel Maintains Buy on Legence, Lowers Price Target to $82

Benzinga Newsdesk www.benzinga.com Negative 73.9%

Neg 73.9% Neu 0% Pos 0%

Stifel analyst Brian Brophy maintains Legence (NASDAQ:LGN) with a Buy and lowers the price target from $101 to $82.

Comments

No comments yet. Be the first!